Legal Advantage Investments Inc. Makes New $358,000 Investment in GRAIL, Inc. $GRAL

Key Points

• Legal Advantage Investments Inc. has acquired 14,000 shares of GRAIL, Inc. (NASDAQ:GRAL), valued at approximately $358,000, during the first quarter.
• GRAIL's stock recently reported a 5.3% decline and has a current market cap of $1.16 billion, with a significant twelve-month trading range of $12.33 to $63.99.
• Insider transactions include CFO Aaron Freidin selling 8,000 shares and major shareholder Chun R. Ding selling 339,800 shares, indicating notable trading activity among company insiders.

Legal Advantage Investments Inc. bought a new stake in GRAIL, Inc. (NASDAQ:GRAL - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 14,000 shares of the company's stock, valued at approximately $358,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. State of Tennessee Department of Treasury acquired a new stake in GRAIL in the fourth quarter valued at about $28,000. Caldwell Sutter Capital Inc. acquired a new position in GRAIL during the first quarter worth about $28,000. Sterling Capital Management LLC bought a new position in shares of GRAIL in the fourth quarter worth about $29,000. KBC Group NV lifted its holdings in shares of GRAIL by 187.7% in the first quarter. KBC Group NV now owns 1,430 shares of the company's stock worth $37,000 after acquiring an additional 933 shares during the last quarter. Finally, S.A. Mason LLC boosted its stake in shares of GRAIL by 50.1% in the 1st quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock valued at $38,000 after purchasing an additional 500 shares in the last quarter.

GRAIL Trading Up 2.4%

NASDAQ GRAL traded up $0.75 during mid-day trading on Wednesday, hitting $32.17. The company's stock had a trading volume of 885,448 shares, compared to its average volume of 914,057. The firm has a market capitalization of $1.16 billion, a price-to-earnings ratio of -2.45 and a beta of 3.26. The company's 50 day simple moving average is $39.52 and its 200 day simple moving average is $36.29. GRAIL, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing the consensus estimate of ($3.14) by ($0.04). The business had revenue of $35.54 million during the quarter, compared to the consensus estimate of $37.57 million. GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. As a group, research analysts forecast that GRAIL, Inc. will post -15.15 EPS for the current year.

Insider Buying and Selling at GRAIL

In other news, CFO Aaron Freidin sold 8,000 shares of the business's stock in a transaction that occurred on Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total value of $311,440.00. Following the transaction, the chief financial officer owned 286,020 shares in the company, valued at $11,134,758.60. The trade was a 2.72% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Joshua J. Ofman sold 9,692 shares of the company's stock in a transaction that occurred on Monday, June 30th. The shares were sold at an average price of $52.00, for a total value of $503,984.00. Following the completion of the transaction, the president directly owned 492,076 shares of the company's stock, valued at approximately $25,587,952. This represents a 1.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 361,694 shares of company stock worth $17,780,266. Corporate insiders own 1.85% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group upped their price objective on shares of GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $31.50.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.